Tedeschi C, Lohman C, Hazum E, Ittoop O, Ben-Shlomo I, Resnick C E, Payne D W, Adashi E Y
University of Maryland Medical School, Department of Obstetrics/Gynecology, Baltimore 21201.
Biol Reprod. 1994 Nov;51(5):1058-65. doi: 10.1095/biolreprod51.5.1058.
Endothelins (ETs) are a family of vasoactive peptides that may be involved in granulosa cell (GC) luteinization or follicular maturation. However, the precise role of ET in ovarian physiology remains unknown. We have investigated whether the rat GC is a site of ET reception and have characterized the antigonadotropic effect of ET in cultured GC from immature rats. Two major ET binding species (52 and 30 kDa) were observed after cross-linking of GC membranes with radiolabeled ET-1, although the smaller protein may represent a degradative product. Unlabeled ET-1, ET-2, or ET-3 were equipotent in displacing radiolabeled ET-1 from these putative ET receptors, with EC50s of 0.3-0.7 x 10(-9) M. Similarly, ET-1, ET-2, and ET-3 were equipotent (EC50s of about 10(-10) to 10(-9) M) in inhibiting the FSH-supported accumulation of progesterone. ET-1 (10(-7) M) also inhibited (> 90%) FSH-supported estrogen accumulation. Maximum progesterone inhibition (> 90%) by ET-1 (10(-7) M) was achieved throughout the range of FSH does and cell densities tested and by 48 h or 72 h of culture. ET-1 was not cytotoxic in the dose range tested. Forskolin-stimulated progesterone accumulation was similarly inhibited by ET-1, suggesting that ET-1 inhibits cAMP-mediated (e.g., FSH or forskolin-stimulated) progesterone accumulation. ET-1 inhibited (74%) the FSH-stimulated accumulation of cAMP, suggesting that it acts at sites related to cAMP generation or degradation. In addition, ET-1 inhibited 8-bromo-cAMP-generated progesterone accumulation (60%), suggesting that it also acts at sites distal to cAMP generation.(ABSTRACT TRUNCATED AT 250 WORDS)
内皮素(ETs)是一类血管活性肽,可能参与颗粒细胞(GC)的黄体化或卵泡成熟过程。然而,ET在卵巢生理学中的具体作用仍不清楚。我们研究了大鼠GC是否为ET的受体位点,并对ET对未成熟大鼠培养GC的促性腺激素抑制作用进行了表征。用放射性标记的ET-1交联GC膜后,观察到两种主要的ET结合蛋白(52和30 kDa),尽管较小的蛋白可能是降解产物。未标记的ET-1、ET-2或ET-3在从这些假定的ET受体上取代放射性标记的ET-1方面具有同等效力,EC50为0.3 - 0.7×10(-9) M。同样,ET-1、ET-2和ET-3在抑制FSH支持的孕酮积累方面具有同等效力(EC50约为10(-10)至10(-9) M)。ET-1(10(-7) M)也抑制(>90%)FSH支持的雌激素积累。在测试的FSH剂量和细胞密度范围内以及培养48小时或72小时时,ET-1(10(-7) M)对孕酮的最大抑制率(>90%)得以实现。在测试的剂量范围内,ET-1没有细胞毒性。佛司可林刺激的孕酮积累同样受到ET-1的抑制,这表明ET-1抑制cAMP介导的(如FSH或佛司可林刺激的)孕酮积累。ET-1抑制(74%)FSH刺激的cAMP积累,这表明它作用于与cAMP产生或降解相关的位点。此外,ET-1抑制8-溴-cAMP产生的孕酮积累(60%),这表明它也作用于cAMP产生位点的下游。(摘要截短于250字)